P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and neuropathic pain.

Market Analysis and Insights: Global P2X7 Receptor Antagonists Market
The global P2X7 Receptor Antagonists market size is projected to reach US$ 112.7 million by 2027, from US$ 54 million in 2020, at a CAGR of 10.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global P2X7 Receptor Antagonists market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global P2X7 Receptor Antagonists market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global P2X7 Receptor Antagonists market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global P2X7 Receptor Antagonists market.

Global P2X7 Receptor Antagonists Scope and Market Size
P2X7 Receptor Antagonists market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global P2X7 Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others

Segment by Application
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer